Philadelphia transplant programs risk losing U.S. funds
The failure to attract enough patients amid heavy competition among Philadelphia-area organ-transplant programs has closed one and put two others at risk. The liver program at Hahnemann University Hospital and the heart-transplant program at Temple University Hospital are in jeopardy of losing Medicare certification and government payments for the operations. Hahnemann and Temple were among a first wave of transplant hospitals nationwide to face intensified scrutiny of surgical volumes and outcomes from federal regulators. Both have until early May to get their numbers back up.
- ICD-10 Delay Alters Provider, Vendor Prep
- Providers Lag as Consumers Set Agenda
- Esther Dyson Launches Population Health Challenge
- Crisis Spurs Healthcare Payment Reform in Arkansas
- Payment Reform Naysayers 'Better Wake Up'
- HIT Leaders Want Flexibility, Transparency from Next HHS Chief
- Look Beyond Nurse-Patient Ratios
- As Hospitalist Patient Loads Rise, So Do Hospital Costs
- Reduce Readmissions by Activating Patients to Do 'Self-Care'
- Advance Directives: Let's Make a Law